Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CM.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EU.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.17.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.42.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.529 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.41.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used